Results 71 to 80 of about 31,914 (284)

Label Adherence for Non-Vitamin K Antagonist Oral Anticoagulants in a Prospective Cohort of Asian Patients with Atrial Fibrillation

Yonsei medical journal, 2019
Purpose Label adherence for non-vitamin K antagonist oral anticoagulants (NOACs) has not been well evaluated in Asian patients with non-valvular atrial fibrillation (AF).
So Ryoung Lee, Young Soo Lee, Ji Suck Park, M. Cha, Tae Hoon Kim, Junbeom Park, Jin-Kyu Park, Jung Myung Lee, Ki-Woon Kang, J. Shim, J. Uhm, Jun Kim, Changsoo Kim, Jin Bae Kim, H. Park, B. Joung, E. Choi   +16 more
semanticscholar   +1 more source

Non-Vitamin K Antagonist Oral Anticoagulants in Adult Congenital Heart Disease [PDF]

Canadian Journal of Cardiology, 2019
Non-vitamin K antagonist (VKA) oral anticoagulants (NOACs) have several advantages over VKAs that render them an attractive option for adults with congenital heart disease (CHD). Efficacy and safety data specific to the adult CHD population are emerging.
François-Pierre, Mongeon, Laurent, Macle, Luc M, Beauchesne, Berto J, Bouma, Markus, Schwerzmann, Barbara J M, Mulder, Paul, Khairy   +6 more
openaire   +2 more sources

Human vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky, Stefan Engeli, Stefanie M. Bode‐Böger, Felix Koop, Martin Schulze Westhoff, Sebastian Schröder, Carsten Schumacher, Thorben Pape, Dirk O. Stichtenoth, Johannes Heck   +9 more
wiley   +1 more source

Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation

TH Open, 2018
Background Vitamin K antagonists (VKAs) are associated with coronary artery calcification in low-risk populations, but their effect on calcification of large arteries remains uncertain.
Frederique E. C. M. Peeters, Elton A. M. P. Dudink, Dorien M. Kimenai, Bob Weijs, Sibel Altintas, Luuk I. B. Heckman, Casper Mihl, Leon J. Schurgers, Joachim E. Wildberger, Steven J. R. Meex, Bas L. J. H. Kietselaer, Harry J. G. M. Crijns   +11 more
doaj   +1 more source

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]

, 2018
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M, Hirsh J, Ibanez B, Mega JL, Park KW, Suh JW, Valgimigli M   +6 more
core   +3 more sources

Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer

British Journal of Clinical Pharmacology, EarlyView.
Aims Treatment with enzalutamide in prostate cancer is challenging due to its high potential for drug–drug interactions, particularly in the typically older population of patients with frequent comorbidities treated with multiple drugs, such as anticoagulants.
Catharina J. P. Op 't Hoog, Niven Mehra, Anouk van Kleef, Diederik M. Somford, Inge M. van Oort, Alex L. T. Imholz, Paul Hamberg, Nielka P. van Erp, Emmy Boerrigter   +8 more
wiley   +1 more source

Dental management of patients taking novel oral anticoagulants (NOAs): dabigatran [PDF]

, 2017
A new group of oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban) with clear advantages over classic dicoumarin oral anticoagulants (warfarin and acenocoumarol) has been developed in recent years.
Albaladejo Martínez, Alberto, Alvarado Lorenzo, Alfonso, Curto Aguilera, Adrián   +2 more
core   +2 more sources

Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants [PDF]

British Journal of Anaesthesia, 2018
Non-vitamin K antagonist oral anticoagulants (NOACs), which inhibit thrombin (dabigatran) and factor Xa (rivaroxaban, apixaban, edoxaban) have been introduced in several clinical indications. Although NOACs have a favourable benefit-risk profile and can be used without routine laboratory monitoring, they are associated-as any anticoagulant-with a risk ...
Eikelboom, J.W., Kozek-Langenecker, S., Exadaktylos, A., Batorova, A., Boda, Z., Christory, F., Gornik, Ivan, Kėkštas, G., Kher, A., Komadina, R., Koval, O., Mitic, G., Novikova, T., Pazvanska, E., Ratobilska, S., Sütt, J., Winder, A., Zateyshchikov, D.   +17 more
openaire   +4 more sources

Comparative effectiveness and safety of oral anticoagulants in patients with atrial fibrillation using antiarrhythmic drugs: An international cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aim Our international cohort study assessed the comparative effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) among patients with non‐valvular atrial fibrillation (NVAF) using antiarrhythmic drugs. Methods Using the United Kingdom's (UK's) Clinical Practice Research Datalink Aurum and Québec claims data, we
Fabian Maximilian Meinert, Jenny Dimakos, Ying Cui, Kristian B. Filion, Christel Renoux, Antonios Douros   +5 more
wiley   +1 more source

Outcome of intracerebral hemorrhage associated with different oral anticoagulants [PDF]

, 2017
Objective: In an international collaborative multicenter pooled analysis, we compared mortality, functional outcome, intracerebral hemorrhage (ICH) volume, and hematoma expansion (HE) between non-vitamin K antagonist oral anticoagulation-related ICH ...
Ambler, Gareth, Basir, Ghazala, Boulanger, Marion, Choi, Philip M. C., Cordonnier, Charlotte, CROMIS-2 Collaborators, Dowlatshahi, Dar, Engelter, Stefan T., Ferrigno, Marc, Houben, Rik, Jaeger, Hans R., Jeng, Jiann-Shing, Meretoja, Atte, Parry-Jones, Adrian R., Perry, Luke A., Purrucker, Jan C., Rizos, Timolaos, Sallinen, Hanne, Salman, Rustam Al-Shahi, Schreuder, Floris H. B. M., Seiffge, David J., Shakeshaft, Clare, Sobowale, Oluwaseun A., Staals, Julie, Tanaka, Jun, Traenka, Christopher, Veltkamp, Roland, Werring, David J., Wilson, Duncan, Wu, Teddy Y., Yakushiji, Yusuke, Yeh, Shin-Joe   +31 more
core   +4 more sources